Contact this trialFirst, we need to learn more about you.
mTOR Inhibitor
Everolimus for Liver Transplant
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial aims to see if it's safe to stop using a certain anti-rejection drug called tacrolimus after a liver transplant. The study will involve 270 participants who will be split into two
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.